Add Formweb to your mobile device
Search results for:
hyaluronidase-rituximab
hyaluronidase-rituximab
Brand names: Rituxan Hycela
| Form | Strength | ANAN | ASMP | LACH | LALK | LOHH | LOLR | LOWC | SDSD | SESE | SFSF | Formulary Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SOLUTION, SUBCUTANEOUS | 23,400 units-1400 mg/11.7 mL; 1400 mg/11.7 mL (15 mL); 1600 mg/13.4 mL | Restricted |
Last updated: Nov. 17, 2023
- Black Box Warning: Fatal Infusion Reaction; Mucocutaneous Reactions; Progressive Multifocal Leukoencephalopathy; Hep b Reactivation
- Do Not Tube-LALK
- Restricted: hyaluronidase-rituximab (Rituxan Hycela) is restricted to use in the Outpatient setting
Initiate treatment with Rituxan Hycela only after patients have received at least one full dose of a rituximab product by IV injection.
Not indicated for the treatment of non-malignant conditions.